Houston, TX -- (SBWIRE) -- 02/19/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Strategic Hotels & Resorts Inc.(NYSE:BEE) is higher 0.13% and is trading at $7.84. Strategic Hotels & Resorts, Inc. (SHR) operates as a self-administered and self-managed real estate investment trust (REIT). As of December 31, 2011, the Company’s portfolio included 17 full-service hotel interests located in urban and resort markets in the United States; Punta Mita, Nayarit, Mexico; Hamburg, Germany, and London, England.
Can BEE Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Vonage Holdings Corp.(NYSE:VG) is lower 1.86% and is trading at $2.64. Vonage Holdings Corp. (Vonage) is a provider of communications services connecting people through broadband devices worldwide. The Company’s network include session initiation protocol (SIP) based voice over Internet protocol (VoIP), network on the Internet.
How Should Investors Trade VG After The Recent Volatile Moves? Find Out Here
American Capital Mortgage Investment Crp(NASDAQ:MTGE) added 0.08% and is trading at $26.04. American Capital Mortgage Investment Corp. was formed to invest in and manage a leveraged portfolio of agency mortgage investments, non-agency mortgage investments and other mortgage-related investments. The Company’s investment objective is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation.
Is MTGE Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
PDL BioPharma Inc.(NASDAQ:PDLI) is higher 0.29% and is trading at $6.96. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Can PDLI Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)